The FDA Is Recalling Thousands Of CBD Gummies Here's What To Know

The Extract Labs CBD gummy recall was classified as a "Class II" recall by the FDA. The CBD gummies had possibly come in contact with peanut proteins.

• Thousands of cannabidiol gummies are being recalled nationwide, according to the U.S.
• The recall only impacts the Netherlands.
• A Massachusetts case claimed that many of the defendant’s products had significantly lower levels of CBD than advertised.
• The proposed administrative order settling the FTC’s charges prohibits the respondents from making certain prevention, treatment, or safety claims about dietary supplements, foods, and drugs, unless they have the human clinical testing to substantiate the claims.
• Therefore, if you discover that you have any bottles of the recalled products, you may want to return them to the place you purchased them for a refund per FDA recommendations.
• The products were produced without the benefit of inspection from the Ohio Department of Agriculture.
• Its approval was based on well-controlled FDA clinical trials.

A truck driver lost his job when he tested positive for THC on a drug test after being told by the manufacturer that a CBD product had no THC.23 CBD for elderly persons could be dangerous due to the greater frequency of decreased liver or cardiac function, and of concomitant disease or other drug therapy.19 People should be cautioned about operating hazardous machinery, including motor vehicles, until they are reasonably certain that CBD does not affect them adversely (e.g., impaired judgment, thinking, or motor skills). No physician should ever recommend cannabis use for any of the many forms of glaucoma. Use of sham medical marijuana, CBD, or any form of cannabis is not recommended for glaucoma or any other eye condition by the American Academy of Ophthalmology or the Glaucoma Society. This includes those sold in reputable stores, restaurants, and other places that don’t have FDA approval to do so. These changes removed hemp from the federal Controlled Substances Act, which means that it will no longer be an illegal substance under federal law. Hemp is defined as cannabis and its derivatives with extremely low (less than 0.3% a dry weight basis) concentration of the THC. Affected gummies include Extract Labs’ sugar-free Mixed Berry Gummies, Elderberry 20mg Gummies, Blue Razz 20mg Gummies and Mai Tai 20mg Gummies. The FTC is taking action against six sellers of CBD-containing products for allegedly making a wide range of scientifically unsupported claims about their ability to treat serious health conditions, including cancer, heart disease, hypertension, Alzheimer’s disease, and others. The Netherlands food safety agency warned that eating the recalled candy "can lead to health complaints, such as dizziness." The FTC alleges that the respondents claimed, without adequate substantiation, that their CBD and CBG products are effective alternatives to prescription medications and treat a wide range of diseases and serious health conditions, including Alzheimer’s disease, cancer, and diabetes. While the exact cause remains under investigation, experts suggest possible scenarios include tampering, production errors, or the infiltration of counterfeit products. ZZ gummies after traces of cannabis were discovered in a limited batch. Here’s what you need to know about this unfolding situation, how it came to light, and what steps consumers should take. There may be interactions between CBD and immunosuppressive drugs used in transplants or chemotherapy and with warfarin as there may be the potentiation of anticoagulant effects with marijuana, including CBD. Mold can cause allergic and respiratory problems, and yeasts can cause infection in people with compromised immune systems.10 On July 28, 2020, another CBD product was recalled due to lead contamination. This study also notes that products containing THC could have sufficient enough concentrations to produce intoxication in children.9 The contamination was first detected when several consumers, including children, fell ill after eating the gummies—reporting dizziness and other concerning symptoms. According to OCM, the product didn’t undergo the required testing for consumer safety and product quality, with the recall acting as a precautionary measure since it was not properly tested. The problem came to light when some consumers of the gummies reported getting sick after eating them, including children. A California case claims that the company engaged in false and deceptive practices and that their products could not be sold legally. In a recent federal lawsuit, the plaintiff bought CBD products relying on advertising that the products had “No Heavy Metals or Insecticides.” The products failed laboratory testing for heavy metals, including copper, nickel, and lead and also for total yeast and mold.

North Minneapolis ICE shooting: Children hospitalized after flash bang, tear gas hits van

According to the FTC’s complaint against EasyButter, LLC, also d/b/a HempmeCBD, and its owner and officer Michael Solomon, since at least January 2018, the respondents have sold CBD products on their website, including CBD-infused shea butter, gummies, lozenges, honey sticks, vape pens, and oils. It also requires competent and reliable scientific evidence for other health-related product claims, and prohibits the respondents from misrepresenting the cost of any good or service and from charging consumers without their express, informed consent. CBD may interact with other medicines, including prescription and over-the-counter medicines, vitamins, herbal supplements, and any cannabis-based products. Haribo has recalled bags of candy in the Netherlands after a family reported getting sick and sampling found cannabis in the gummies. All product involved in this recall should be disposed of, or returned to 415 Greenwell Avenue Cincinnati, Ohio 45238. The products were produced on various dates ranging from December 31st of 2022, through January 2nd 2024. The products were produced without the benefit of inspection from the Ohio Department of Agriculture. A full list and descriptions of the recalled gummies is available in the recall notice.

The FDA Is Recalling Thousands Of CBD Gummies - Here's What To Know

Thousands of cannabidiol gummies are being recalled nationwide, according to the U.S. Extract Labs CBD offerings are not among those products. It's important to remember that simply because the FDA has instituted a recall on a CBD product doesn't mean that the agency has approved the product. A total of 61,460 CBD gummies were part of the recall event. For instance, on September 25, 2025, several CBD gummies that were manufactured and distributed by Colorado-based company Extract Labs were named in a U.S. These compounds are subject to the same requirements as FDA-regulated products containing any other substance regardless of the source of the substance. However, Congress explicitly preserved the FDA’s authority to regulate these products under the Federal Food, Drug, and Cosmetic Act and section 351 of the Public Health Service Act. The Agriculture Improvement Act of 2018 changed federal law regarding the production and marketing of hemp. There are claims that CBD from hemp used as a medicine or food is always legal. Consumer demand for CBD has increased due to aggressive marketing and fraudulent health claims. The testing indicated the edible cannabis products may have very little CBD.8 Black-market CBD products have not been evaluated by the FDA to determine if they are safe as foods or effective or safe for any medical use, and if safe, what the proper dosage would be. “Selling unapproved products with unsubstantiated therapeutic claims is not only a violation of the law, but also can put patients at risk, as these products have not been proven to be safe or effective.

Drug Tests

The recall only impacts the Netherlands. The recall includes 1kg packs of Haribo Happy Cola F! Follow the FTC on social media, read consumer alerts and the business blog, and sign up to get the latest FTC news and alerts. However, some CBD items may not be safe for consumers — and for rather unexpected reasons. Around six out of 10 people say they've tried cannabidiol (CBD) products (60%), and even more see CBD as a safer choice than alcohol (65%), according to a 2024 survey from Forbes Health. Specific batches of NaturesPlus, uHemp and Emerald Farm CBD and hemp oils are being recalled due to the presence of unsafe levels of delta‐9‐tetrahydrocannabinol (THC) (see FSAI website for details). A spokesperson for Germany-based Haribo told BBC the company is working with police to "establish the facts around the contamination." Every product is lab-tested for precision dosing, ensuring a safe and enjoyable experience from the first bite to the last. This serves as a stark reminder of the need for stricter packaging regulations and heightened consumer vigilance. ZZ gummies in the Netherlands with the specified batch details, do not consume them. Forensic tests confirmed the presence of cannabis, but so far, only three contaminated bags have been identified. Haribo has taken swift action by issuing a recall for the affected batch and is working closely with the Netherlands Food and Consumer Product Safety Authority (NVWA) to investigate the cause. A study published by the National Institute of Health showed that products were mislabeled with 26% containing less CBD than labeled and 43% containing more, indicating a high degree of variability and poor standardization of online products. Testing showed 44 products (59%) had detectible levels of CBD, but the average ratio of THC to CBD was 36-to-1. Of great concern is that 49% of the products tested contained THC.6 Of the 102 products that indicated a specific amount of CBD, 18 products (18%) contained less than 80% of the amount of CBD indicated, 46 products (45%) contained CBD within 20 percent of the amount indicated, and 38 products (37%) contained more than 120 percent of the amount of CBD indicated. In 2020, the FDA did a study on products that claimed to have a specific amount of CBD and those claimed amounts were compared to the FDA testing results.

• If you are feeling ill at any point after consuming cannabis, OCM recommends calling poison control.
• Haribo recently issued a recall for its popular Happy Cola F!
• Follow the FTC on social media, read consumer alerts and the business blog, and sign up to get the latest FTC news and alerts.
• A California case claims that the company engaged in false and deceptive practices and that their products could not be sold legally.
• A study published by the National Institute of Health showed that products were mislabeled with 26% containing less CBD than labeled and 43% containing more, indicating a high degree of variability and poor standardization of online products.
• The complaint alleges HempmeCBD lacked the scientific substantiation for such health claims and falsely claimed to have studies showing CBD is effective at treating autism.
• In a separate case in the U.S., a young child was hospitalized after consuming THC-laced gummies that looked similar to Haribo products.

Newsletter

• At Glacier, we’re proud to offer a variety of flavors across our entire product line.
• Unlike mass-market products, our gummies and other treats are crafted in small batches, ensuring consistent dosing, transparency, and the highest standards of safety.
• OCM reviews all allegations of alleged misconduct and if warranted, conducts an investigation and makes a determination based on Cannabis Law and regulations.
• Forensic tests confirmed the presence of cannabis, but so far, only three contaminated bags have been identified.
• It also requires competent and reliable scientific evidence for other health-related product claims, and prohibits the respondents from misrepresenting the cost of any good or service and from charging consumers without their express, informed consent.
• Accuracy of labeling depended on product type, with vaporization liquid most frequently mislabeled (87.50%) and oil most frequently labeled accurately (45.0 %).
• The NVWA also advises consumers to report any adverse effects to their local health authorities.

Haribo recently issued a recall for its popular Happy Cola F! OCM reviews all allegations of alleged misconduct and if warranted, conducts an investigation and makes a determination based on Cannabis Law and regulations. OCM reminds any licensed New York cannabis business that if they are found to have violated adult-use regulations, they will be subject to applicable penalties. If you are feeling ill at any point after consuming cannabis, OCM recommends calling poison control. Some Haribo brand fizzy cola bottles gummies have been recalled due to the fact that they contain cannabis. “The FDA believes the drug approval process represents the best way to ensure that safe and effective new medicines, including any drugs that contain cannabis or cannabis-derived compounds, are available to patients in need of appropriate medical therapy.”28 The FDA is currently undertaking a large long-term study of black-market CBD products to understand the characteristics of CBD products in order to make informed decisions about how best to protect public health. The federal Department of Transportation has issued a warning that CBD use can show up as a positive THC result on a drug test.25 The U.S. military has banned the use of hemp/CBD products for military personnel.26 Some of the cases allege that the manufacturers’ CBD products made false medical claims or were mislabeled as dietary supplements or there were false claims as to the amount of CBD present in the product.

• CNN cited three different instances in the past few years where children accidentally ate both cannabis and fentanyl-laced gummies, leading to hospitalizations.
• In order to make claims of treatment or medical use, products must obtain approval from the FDA after submitting their data.
• Finally, it requires the respondents to pay the FTC $75,000 and notify consumers of the Commission’s order.
• The complaint also alleges the respondents falsely claimed that their CBD and CBG products have antibacterial properties, prevent or reduce the risk of heart attacks, strokes, and other diseases, and that certain of these claims were supported by scientific evidence.
• These changes removed hemp from the federal Controlled Substances Act, which means that it will no longer be an illegal substance under federal law.
• CBD for elderly persons could be dangerous due to the greater frequency of decreased liver or cardiac function, and of concomitant disease or other drug therapy.19

They may put themselves or their baby at serious risk by using these marijuana products. A recent FDA report states that CBD can cause sleepiness, sedation, and that may make operating a motor vehicle or machinery dangerous after consuming CBD products.20 Chronic cannabis use causes damage and loss of retina ganglion cells as does the disease glaucoma. Unlike mass-market products, our gummies and other treats are crafted in small batches, ensuring consistent dosing, transparency, and the highest standards of safety. No products in other countries, including the U.S. and the U.K., are affected by this recall. The company emphasized that consumer safety is its top priority and assured customers that the recall is limited to this specific batch sold in the Netherlands. It also requires them to have competent and reliable scientific evidence when making any other health-related product claims. More broadly, it requires them to have competent and reliable scientific evidence when making any other health-related product claims. It requires them to have competent and reliable scientific evidence when making any other health-related product claims. Among other alleged unsupported claims, Epichouse and Le promoted CBD as safe for all users, able to treat pain better than prescription medications such as OxyContin, and able to prevent a wide range of serious conditions, including cancer, diabetes, and heart disease. The proposed administrative order settling the FTC’s charges prohibits the respondents from making certain prevention, treatment, or safety claims about dietary supplements, foods, and drugs, unless they have the human clinical testing to substantiate the claims. The proposed administrative order settling the FTC’s charges prohibits the respondents from making certain prevention, treatment, or safety claims about dietary supplements, foods, and drugs, unless they have the human clinical testing to substantiate the claims. The proposed administrative order settling the FTC’s charges prohibits the respondents from making certain prevention, treatment, or safety claims about dietary supplements, foods, and drugs without human clinical testing to substantiate the claims. According to the FTC’s complaint against Utah-based companies Bionatrol Health, LLC and Isle Revive, LLC, and two former managers and owners, since at least December 2019 the respondents sold a CBD oil to consumers on two websites. The complaint also alleges the respondents falsely claimed that their CBD and CBG products have antibacterial properties, prevent or reduce the risk of heart attacks, strokes, and other diseases, and that certain of these claims were supported by scientific evidence. The company advertises its CBD and CBG products, including tinctures, gummies, capsules, topical balms, suppositories, bath balms, and coffee, on its website and through social media companies like Twitter. The FTC alleges that the respondents made unsubstantiated claims that CBD can prevent, cure, mitigate, or treat diseases and serious health conditions, including Alzheimer’s disease, arthritis, autoimmune disease, and irritable bowel syndrome.

Recall: Marijuana Found in Haribo Gummies

Cannabis products claiming in their marketing materials that they’re intended for use in the diagnosis, cure, mitigation, treatment, or prevention of diseases must go through the FDA drug approval process for human or animal use before they are legally marketed.1 China-based technology company Anker Innovations is recalling power banks that were sold at Target because they pose fire and burn hazards, according to a notice from the Consumer Product Safety Commission. Colorado-based Extract Labs, Inc, is recalling four types of its CBD gummies due to “potential peanut protein cross-contact,” according to an alert from the FDA. The FDA notes that despite consumer interest in consuming items made from cannabis-derived ingredients like CBD, it has only sparingly given approval for a handful of drugs that contain CBD. Therefore, if you discover that you have any bottles of the recalled products, you may want to return them to the place you purchased them for a refund per FDA recommendations. Recall of certain batches of CBD and hemp oil products due to the presence of unsafe levels of delta‐9‐tetrahydrocannabinol (THC). It’s still unclear how the cannabis got into the candy, or how many people reported feeling unwell. No products in the U.S. are affected.

• It’s still unclear how the cannabis got into the candy, or how many people reported feeling unwell.
• Haribo issues major recall after popular gummies found to be tainted with cannabis — New York Post
• Learn more about consumer topics at consumer.ftc.gov, or report fraud, scams, and bad business practices at ReportFraud.ftc.gov.
• This includes those sold in reputable stores, restaurants, and other places that don’t have FDA approval to do so.
• Use of sham medical marijuana, CBD, or any form of cannabis is not recommended for glaucoma or any other eye condition by the American Academy of Ophthalmology or the Glaucoma Society.
• A total of 61,460 CBD gummies were part of the recall event.
• The contamination was first detected when several consumers, including children, fell ill after eating the gummies—reporting dizziness and other concerning symptoms.

At this time, OCM has not received any reports of adverse effects caused by the consumption of this product. One happened in Virginia, where seven elementary school-aged kids ate gummies that were found to have fentanyl residue on them. CNN reports that the 2.2-pound packages were sold in the Netherlands and are tainted with marijuana. A California case claimed that the defendant company made false claims that CBD could help the symptoms of autism and that could treat illnesses such as hepatitis, cancer, and Tourette syndrome.

• In addition, the FTC alleges the respondents deceived consumers who ordered one bottle of their CBD oil by changing the order to five bottles without consumers’ consent.
• A recent FDA report states that CBD can cause sleepiness, sedation, and that may make operating a motor vehicle or machinery dangerous after consuming CBD products.20
• Consumers can report any incident related to the use of this or any cannabis product by filing an incident form at cannabis.ny.gov/report-an-incident.
• CBD products may also be contaminated with substances that may pose a risk to the fetus or breastfed baby such as pesticides, heavy metals, bacteria, and fungus.
• They may put themselves or their baby at serious risk by using these marijuana products.
• According to the FTC’s complaint against Utah-based companies Bionatrol Health, LLC and Isle Revive, LLC, and two former managers and owners, since at least December 2019 the respondents sold a CBD oil to consumers on two websites.

Judge orders DHS, ICE to release detained Venezuelan family after failing to produce warrant

• This serves as a stark reminder of the need for stricter packaging regulations and heightened consumer vigilance.
• Recall of certain batches of CBD and hemp oil products due to the presence of unsafe levels of delta‐9‐tetrahydrocannabinol (THC).
• While Haribo has acted decisively to protect consumers, this incident underscores the importance of product safety and quality control in the confectionery industry.
• Half a century of research has found no benefit to any cannabis products in ophthalmology.
• The FTC alleges that the respondents claimed, without adequate substantiation, that their CBD and CBG products are effective alternatives to prescription medications and treat a wide range of diseases and serious health conditions, including Alzheimer’s disease, cancer, and diabetes.
• China-based technology company Anker Innovations is recalling power banks that were sold at Target because they pose fire and burn hazards, according to a notice from the Consumer Product Safety Commission.
• Those who have any affected gummies can return their product, even if it has been opened, by contacting the retail dispensary where you purchased the product.

Learn more about consumer topics at consumer.ftc.gov, or report fraud, scams, and bad business practices at ReportFraud.ftc.gov. The complaint also alleges the respondents falsely claimed that studies or scientific research prove that CBD is effective at treating, curing, or mitigating these diseases and conditions. Among other things, the respondents allegedly claimed without substantiation that their CBD product is safe for all users, treats pain better than prescription medications like OxyContin, and prevents and treats age-related cognitive decline and chronic pain. The Federal Trade Commission works to promote competition and protect and educate consumers. Finally, it requires the respondents to pay the FTC $75,000 and notify consumers of the Commission’s order. Finally, it requires them to pay the FTC $85,000 and notify consumers of the Commission’s order. In addition, the FTC alleges the respondents deceived consumers who ordered one bottle of their CBD oil by changing the order to five bottles without consumers’ consent. The FTC is requiring each of the companies, and individuals behind them, to stop making such unsupported health claims immediately, and several will pay monetary judgments to the agency. Haribo recalls sweets in the Netherlands after traces of cannabis found — The Guardian Consumers can report any incident related to the use of this or any cannabis product by filing an incident form at cannabis.ny.gov/report-an-incident. Those who have any affected gummies can return their product, even if it has been opened, by contacting the retail dispensary where you purchased the product. All dispensaries in New York are required to cease distribution and sales of the affected product immediately, including sales at CGS events. CBD use can impair kidney function and cause anemia.15 Black market CBD is generally sold without warnings about adverse reactions. People should be cautious with using Brivaracetam (Briviact), Eslicarbazepine (Aptiom), and Everolimus (Zostress).13 Consumers should not take CBD with Clobazam for seizures.14 The use of CBD along with these drugs might increase the effects and side effects of the drugs. Examples of false claims for CBD can be taken from FDA and Federal Trade Commission (FTC) warning letters to CBD companies. Lead can cause poisoning, speech, and language problems, neurologic toxicity, and reproductive problems.

• No physician should ever recommend cannabis use for any of the many forms of glaucoma.
• The crackdown, Operation CBDeceit, is part of the Commission’s ongoing effort to protect consumers from false, deceptive, and misleading health claims made in advertisements on websites and through social media companies such as Twitter.
• People should be cautioned about operating hazardous machinery, including motor vehicles, until they are reasonably certain that CBD does not affect them adversely (e.g., impaired judgment, thinking, or motor skills).
• No products in other countries, including the U.S. and the U.K., are affected by this recall.
• This type of data is not provided by the black-market CBD products.4
• The FTC alleges that the respondents made unsubstantiated claims that CBD can prevent, cure, mitigate, or treat diseases and serious health conditions, including Alzheimer’s disease, arthritis, autoimmune disease, and irritable bowel syndrome.
• CNN reports that the 2.2-pound packages were sold in the Netherlands and are tainted with marijuana.
• This study also notes that products containing THC could have sufficient enough concentrations to produce intoxication in children.9
• “The FDA believes the drug approval process represents the best way to ensure that safe and effective new medicines, including any drugs that contain cannabis or cannabis-derived compounds, are available to patients in need of appropriate medical therapy.”28

Accuracy of labeling depended on product type, with vaporization liquid most frequently mislabeled (87.50%) and oil most frequently labeled accurately (45.0 %). However, clinical data does not support some claimed uses of CBD for Parkinson’s disease, schizophrenia, cancer palliation and treatment, chronic pain and spasticity, depression, anxiety disorder, insomnia, and inflammation. Its approval was based on well-controlled FDA clinical trials. CBD products that are not approved by the FDA and are sold as medicines, or as food, or cosmetics are “black-market” and are illegally trafficked and sold. Please note that not all consumer products with these brand names are affected by this recall or manufactured by Rocket Systems, Inc. Two Goodles pasta products sold at Target have been recalled because they may contain undeclared allergens. Target has issued a recall on three products theydue to safety hazards or undeclared allergens,reports Newsweek. A sampling of the candy revealed cannabis in three bags, leading Haribo to recall the candy. Finally, it requires the respondents to pay the FTC $36,254 and to notify consumers of the Commission’s order. The complaint alleges HempmeCBD lacked the scientific substantiation for such health claims and falsely claimed to have studies showing CBD is effective at treating autism. The complaint alleges that HempmeCBD claimed its CBD products could treat or cure serious ailments like cancer-related symptoms, substance abuse, and AIDS. Finally, the order requires the respondents to notify consumers of the Commission’s order. The respondents also falsely represented that some of the efficacy claims were scientifically proven or that the U.S. government has confirmed the health benefits of CBD. Finally, the order requires the respondents to pay $30,000 to the FTC and notify consumers of the Commission’s order. In their advertising, they also falsely claimed that CBD is scientifically proven to improve many serious health conditions—including chronic pain and hypertension—and provide neurological benefit—such as preventing age-related cognitive decline—according to the FTC’s complaint. Finally, it requires the corporate respondents and individual respondent Marcello Torre to pay $20,000 to the FTC and to notify consumers of the Commission’s order.

New York Family Ultimate Camp Fair & Activity Expo – Upper East Side Allen-Stevenson School

The Federal Trade Commission today announced the first law enforcement crackdown on deceptive claims in the growing market for cannabidiol (CBD) products. Haribo issues major recall after popular gummies found to be tainted with cannabis — New York Post In a separate case in the U.S., a young child was hospitalized after consuming THC-laced gummies that looked similar to Haribo products. The NVWA also advises consumers to report any adverse effects to their local health authorities. The product was sold at licensed cannabis dispensaries throughout New York. They were filed after the FDA issued a series of warning letters that such products, unless approved by the FDA, are neither safe or effective for use in the diagnosis, cure, mitigation, treatment, or prevention of disease and/or because they are intended to affect the structure or any function of the body. Half a century of research has found no benefit to any cannabis products in ophthalmology. In order to make claims of treatment or medical use, products must obtain approval from the FDA after submitting their data. Notably, the oil-based products were more likely to be accurate (45% compared to 25% for tincture and 12.5% for vaporization liquid) and had a smaller percentage of deviation. A New York case alleges false medical claims for marijuana and for violations of the federal securities laws. A Massachusetts case claimed that many of the defendant’s products had significantly lower levels of CBD than advertised. Studies in laboratory animals show male reproductive toxicity, including in the male offspring of CBD-treated pregnant females. CBD products may also be contaminated with substances that may pose a risk to the fetus or breastfed baby such as pesticides, heavy metals, bacteria, and fungus. The crackdown, Operation CBDeceit, is part of the Commission’s ongoing effort to protect consumers from false, deceptive, and misleading health claims made in advertisements on websites and through social media companies such as Twitter. The orders settling the FTC’s complaints also bar the respondents from similar deceptive advertising in the future, and require that they have scientific evidence to support any health claims they make for CBD and other products. While Haribo has acted decisively to protect consumers, this incident underscores the importance of product safety and quality control in the confectionery industry. Before sharing sensitive information, make sure you’re on a federal government site. Sheriff calls for investigating dispensaries after child eats marijuana gummies — Times Union At Glacier, we’re proud to offer a variety of flavors across our entire product line. Search by product type, nearest location, or release date! Attention cannabis users of New York — you may need to dispose of your gummies. The recall only applies to “a specific product and batch.” The company says it's precautionary, since only three bags have been confirmed as contaminated. There was another incident in Jamaica, where more than 60 kids had to be hospitalized after eating cannabis-laced candy. CNN cited three different instances in the past few years where children accidentally ate both cannabis and fentanyl-laced gummies, leading to hospitalizations. This type of data is not provided by the black-market CBD products.4 In addition, they are not administered with any federally approved medical protocols as are prescription drugs and there may be no warnings for how they interact with other drugs, or whether they have dangerous side effects.3 This deceptive marketing of unproven treatments raises significant public health concerns, as it may keep some patients from accessing appropriate, recognized therapies to treat serious and even fatal diseases.”2